피쉬오일 EPA 및 DHA : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)
Fish Oil EPA and DHA - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
상품코드:1873619
리서치사:QYResearch
발행일:2025년 10월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 피쉬오일 EPA 및 DHA 시장 규모는 2024년에 16억 2,500만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 3.4%로 성장하여 2031년까지 20억 2,000만 달러로 확대될 것으로 예측됩니다.
본 보고서는 피쉬오일 EPA 및 DHA의 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호 의존성, 공급망 재구축, 최근 관세 조정 및 국제적인 전략적 대응 조치에 대한 종합적인 평가를 제공합니다.
피쉬오일은 지방이 많은 생선에서 추출한 지방의 일종입니다. 인체에 필수적인 불포화지방산인 에이코사펜타엔산(EPA), 도코사헥사엔산(DHA) 및 각종 n-3 고도불포화지방산(n-3PUFA)을 풍부하게 함유하고 있습니다. EPA는 혈관 내 노폐물을 제거하고 혈관을 유연하게 유지하며 면역력을 향상시키는 작용을 하여 '혈관 청소부'로 알려져 있습니다. DHA는 임산부나 영유아에게 널리 이용되고 있으며, 섭취를 통해 뇌의 정상적인 성장과 발달을 촉진하여 이른바 뇌 기능 향상 및 지능 강화 효과를 발휘합니다. 일반적으로 '뇌의 황금'이라고도 불립니다.
만성질환 증가는 예방영양학을 촉진한다: 심혈관질환, 당뇨병, 신경퇴행성 질환, 전신염증이 전 세계적인 공중보건 이슈로 떠오르면서 예방 및 기능성 영양에 대한 수요가 증가하고 있습니다. EPA는 항염증과 중성지방 감소 효과로 널리 알려져 있으며, DHA는 신경 및 망막 발달을 돕습니다. 이러한 건강 효과로 인해 EPA와 DHA는 일상적인 보충제의 필수 성분으로 자리매김하고 있으며, 의료 전문가들의 권장량이 증가하고 있습니다.
인지 기능 및 뇌 건강에 대한 관심 증가로 DHA 수요 증가: 고령화 사회가 진전되고 아동기 인지 발달에 대한 인식이 높아짐에 따라 DHA는 뇌와 신경계의 주요 구조 성분으로 주목받고 있습니다. 현재 임산부용 보충제, 유아용 조제분유, 노인용 인지기능 지원 제품에 DHA를 함유하는 것이 표준화되어 오메가3 카테고리의 주요 촉진제 역할을 하고 있습니다.
중산층 확대와 건강에 대한 인식이 높은 소비자가 보급을 촉진: 신흥 시장, 특히 아시아태평양에서는 중산층 확대와 건강 문해력 증가로 인해 치료 중심의 의료에서 예방적 자가 관리로의 전환이 가속화되고 있습니다. 피쉬오일 보충제는 장기적인 건강 유지를 목표로 하는 가정에 저렴하고 쉽게 구할 수 있는 건강 투자로 점점 더 많이 인식되고 있습니다.
제약 등급 EPA의 채택으로 임상적 가치 강화: 이코사펜토에틸과 같은 처방용 EPA 제품은 심혈관 위험 감소에 강력한 임상적 효과가 있습니다. 규제 기관과 의료 시스템이 이러한 성과를 널리 수용함에 따라 제약 분야는 고부가가치 성장 기반으로 부상하고 있으며, 오메가3 산업을 의료 영역으로 더욱 발전시키고 있습니다.
정제 기술의 발전으로 품질과 수용성 향상: 기존에는 비린내, 산화, 오염에 대한 우려가 오메가3의 보급을 가로막고 있었습니다. 오늘날 분자 증류, 초임계 CO2 추출, 재에스테르화 기술을 통해 보다 순도가 높고, 맛이 좋으며, 생체 이용 효율이 높은 제품을 생산하여 소비자의 신뢰와 만족도를 크게 향상시켰습니다.
이 보고서는 피쉬오일 EPA 및 DHA 세계 시장에 대해 총 판매량, 매출, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.
피쉬오일 EPA 및 DHA 시장 규모, 추정 및 예측은 판매량(톤) 및 매출액(백만 달러)으로 제시되며, 2024년을 기준 연도로 하여 2020-2031년의 과거 데이터와 예측 데이터를 포함하는 2024년부터 2031년까지의 기간으로 추정 및 예측됩니다. 정량적, 정성적 분석을 통해 독자들이 피쉬오일 EPA 및 DHA에 대한 사업 전략 및 성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 정보에 입각한 사업적 판단을 할 수 있도록 돕습니다.
시장 세분화
기업별
KD Pharma
Croda
BASF
Yuwang Pharma
GC Rieber VivoMega
Pelagia(EPAX)
Golden Omega
TASA
KinOmega Biopharm
Omega Protein
Huatai Phrama
AlaskOmega(Wiley Companies)
Jiangsu Auqi Marine Biotechnology
Sinomega Biotech Engineering
Xinzhou Marine Biological Products
Nu-Mega(Clover)
Skuny Bioscience
Renpu Pharmaceuticals
Polaris
Solutex
유형별 부문
피쉬오일 EPA
피쉬오일 DHA
용도별 부문
식이보충제
강화 식품 및 음료
유아용 조제분유
의약품
반려동물 사료
기타
지역별
북미
미국
캐나다
아시아태평양
중국
일본
한국
동남아시아
인도
호주
기타 아시아태평양
유럽
독일
프랑스
영국
이탈리아
네덜란드
북유럽 국가
기타 유럽
라틴아메리카
멕시코
브라질
기타 라틴아메리카
중동 및 아프리카
튀르키예
사우디아라비아
아랍에미리트(UAE)
기타 중동 및 아프리카
LSH
영문 목차
영문목차
The global market for Fish Oil EPA and DHA was estimated to be worth US$ 1625 million in 2024 and is forecast to a readjusted size of US$ 2020 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Fish Oil EPA and DHA cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Fish oil is a kind of oil extracted from fatty fish. It is rich in eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and various n-3 polyunsaturated fatty acids (n-3PUFA), which are essential unsaturated fatty acids for the human body. EPA can clean up blood vessel waste, soften blood vessels and improve immunity, and is known as the "blood vessel scavenger"; DHA is often used for pregnant women and infants. By taking DHA, it can promote the normal growth and development of the brain, thus playing a so-called brain-boosting and intelligence-enhancing effect, commonly known as "brain gold".
Rising Burden of Chronic Diseases Fuels Preventive Nutrition: As cardiovascular diseases, diabetes, neurodegenerative disorders, and systemic inflammation become global public health challenges, demand for preventive and functional nutrition is rising. EPA is well-known for its anti-inflammatory and triglyceride-lowering effects, while DHA supports neural and retinal development. These health benefits position EPA and DHA as essential components of daily supplementation, increasingly recommended by healthcare professionals.
Growing Focus on Cognitive and Brain Health Accelerates DHA Demand: With aging populations and heightened awareness of childhood cognitive development, DHA is gaining traction as a key structural component of the brain and nervous system. DHA supplementation is now routine in prenatal supplements, infant formula, and cognitive support products for aging adults, making it a central growth driver in the omega-3 category.
Expanding Middle Class and Health-Conscious Consumers Boost Uptake: In emerging markets, especially in Asia-Pacific, the expanding middle class and rising health literacy are driving the shift from curative medicine to preventive self-care. Fish oil supplements are increasingly viewed as affordable and accessible wellness investments by families looking to maintain long-term health.
Pharmaceutical-Grade EPA Adoption Reinforces Clinical Value: Prescription EPA products like icosapent ethyl have demonstrated strong clinical benefits in reducing cardiovascular risk. As more regulatory bodies and health systems embrace these results, the pharmaceutical segment is emerging as a high-value growth pillar, pushing the omega-3 industry further into the healthcare domain.
Advancements in Purification Technology Improve Quality and Appeal: Historically, concerns over fishy taste, oxidation, and contamination hindered broader omega-3 adoption. Today, molecular distillation, supercritical CO2 extraction, and re-esterification techniques have led to purer, better-tasting, and more bioavailable products, greatly enhancing consumer trust and satisfaction.
This report aims to provide a comprehensive presentation of the global market for Fish Oil EPA and DHA, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fish Oil EPA and DHA by region & country, by Type, and by Application.
The Fish Oil EPA and DHA market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fish Oil EPA and DHA.
Market Segmentation
By Company
KD Pharma
Croda
BASF
Yuwang Pharma
GC Rieber VivoMega
Pelagia (EPAX)
Golden Omega
TASA
KinOmega Biopharm
Omega Protein
Huatai Phrama
AlaskOmega (Wiley Companies)
Jiangsu Auqi Marine Biotechnology
Sinomega Biotech Engineering
Xinzhou Marine Biological Products
Nu-Mega (Clover)
Skuny Bioscience
Renpu Pharmaceuticals
Polaris
Solutex
Segment by Type
Fish Oil EPA
Fish Oil DHA
Segment by Application
Dietary Supplements
Fortified Foods and Beverages
Infant Formula
Pharmaceuticals
Pet Foods
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Fish Oil EPA and DHA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Fish Oil EPA and DHA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Fish Oil EPA and DHA in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Fish Oil EPA and DHA Product Introduction
1.2 Global Fish Oil EPA and DHA Market Size Forecast
1.2.1 Global Fish Oil EPA and DHA Sales Value (2020-2031)
1.2.2 Global Fish Oil EPA and DHA Sales Volume (2020-2031)
1.2.3 Global Fish Oil EPA and DHA Sales Price (2020-2031)
1.3 Fish Oil EPA and DHA Market Trends & Drivers
1.3.1 Fish Oil EPA and DHA Industry Trends
1.3.2 Fish Oil EPA and DHA Market Drivers & Opportunity
1.3.3 Fish Oil EPA and DHA Market Challenges
1.3.4 Fish Oil EPA and DHA Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Fish Oil EPA and DHA Players Revenue Ranking (2024)
2.2 Global Fish Oil EPA and DHA Revenue by Company (2020-2025)
2.3 Global Fish Oil EPA and DHA Players Sales Volume Ranking (2024)
2.4 Global Fish Oil EPA and DHA Sales Volume by Company Players (2020-2025)
2.5 Global Fish Oil EPA and DHA Average Price by Company (2020-2025)
2.6 Key Manufacturers Fish Oil EPA and DHA Manufacturing Base and Headquarters
2.7 Key Manufacturers Fish Oil EPA and DHA Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Fish Oil EPA and DHA
2.9 Fish Oil EPA and DHA Market Competitive Analysis
2.9.1 Fish Oil EPA and DHA Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Fish Oil EPA and DHA Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fish Oil EPA and DHA as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fish Oil EPA
3.1.2 Fish Oil DHA
3.2 Global Fish Oil EPA and DHA Sales Value by Type
3.2.1 Global Fish Oil EPA and DHA Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Fish Oil EPA and DHA Sales Value, by Type (2020-2031)
3.2.3 Global Fish Oil EPA and DHA Sales Value, by Type (%) (2020-2031)
3.3 Global Fish Oil EPA and DHA Sales Volume by Type
3.3.1 Global Fish Oil EPA and DHA Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Fish Oil EPA and DHA Sales Volume, by Type (2020-2031)
3.3.3 Global Fish Oil EPA and DHA Sales Volume, by Type (%) (2020-2031)
3.4 Global Fish Oil EPA and DHA Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Dietary Supplements
4.1.2 Fortified Foods and Beverages
4.1.3 Infant Formula
4.1.4 Pharmaceuticals
4.1.5 Pet Foods
4.1.6 Others
4.2 Global Fish Oil EPA and DHA Sales Value by Application
4.2.1 Global Fish Oil EPA and DHA Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Fish Oil EPA and DHA Sales Value, by Application (2020-2031)
4.2.3 Global Fish Oil EPA and DHA Sales Value, by Application (%) (2020-2031)
4.3 Global Fish Oil EPA and DHA Sales Volume by Application
4.3.1 Global Fish Oil EPA and DHA Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Fish Oil EPA and DHA Sales Volume, by Application (2020-2031)
4.3.3 Global Fish Oil EPA and DHA Sales Volume, by Application (%) (2020-2031)
4.4 Global Fish Oil EPA and DHA Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Fish Oil EPA and DHA Sales Value by Region
5.1.1 Global Fish Oil EPA and DHA Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Fish Oil EPA and DHA Sales Value by Region (2020-2025)
5.1.3 Global Fish Oil EPA and DHA Sales Value by Region (2026-2031)
5.1.4 Global Fish Oil EPA and DHA Sales Value by Region (%), (2020-2031)
5.2 Global Fish Oil EPA and DHA Sales Volume by Region
5.2.1 Global Fish Oil EPA and DHA Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Fish Oil EPA and DHA Sales Volume by Region (2020-2025)
5.2.3 Global Fish Oil EPA and DHA Sales Volume by Region (2026-2031)
5.2.4 Global Fish Oil EPA and DHA Sales Volume by Region (%), (2020-2031)
5.3 Global Fish Oil EPA and DHA Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Fish Oil EPA and DHA Sales Value, 2020-2031
5.4.2 North America Fish Oil EPA and DHA Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Fish Oil EPA and DHA Sales Value, 2020-2031
5.5.2 Europe Fish Oil EPA and DHA Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Fish Oil EPA and DHA Sales Value, 2020-2031
5.6.2 Asia Pacific Fish Oil EPA and DHA Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Fish Oil EPA and DHA Sales Value, 2020-2031
5.7.2 South America Fish Oil EPA and DHA Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Fish Oil EPA and DHA Sales Value, 2020-2031
5.8.2 Middle East & Africa Fish Oil EPA and DHA Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Fish Oil EPA and DHA Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Fish Oil EPA and DHA Sales Value and Sales Volume
6.2.1 Key Countries/Regions Fish Oil EPA and DHA Sales Value, 2020-2031
6.2.2 Key Countries/Regions Fish Oil EPA and DHA Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Fish Oil EPA and DHA Sales Value, 2020-2031
6.3.2 United States Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Fish Oil EPA and DHA Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Fish Oil EPA and DHA Sales Value, 2020-2031
6.4.2 Europe Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Fish Oil EPA and DHA Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Fish Oil EPA and DHA Sales Value, 2020-2031
6.5.2 China Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
6.5.3 China Fish Oil EPA and DHA Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Fish Oil EPA and DHA Sales Value, 2020-2031
6.6.2 Japan Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Fish Oil EPA and DHA Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Fish Oil EPA and DHA Sales Value, 2020-2031
6.7.2 South Korea Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Fish Oil EPA and DHA Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Fish Oil EPA and DHA Sales Value, 2020-2031
6.8.2 Southeast Asia Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Fish Oil EPA and DHA Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Fish Oil EPA and DHA Sales Value, 2020-2031
6.9.2 India Fish Oil EPA and DHA Sales Value by Type (%), 2024 VS 2031
6.9.3 India Fish Oil EPA and DHA Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 KD Pharma
7.1.1 KD Pharma Company Information
7.1.2 KD Pharma Introduction and Business Overview
7.1.3 KD Pharma Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 KD Pharma Fish Oil EPA and DHA Product Offerings
7.1.5 KD Pharma Recent Development
7.2 Croda
7.2.1 Croda Company Information
7.2.2 Croda Introduction and Business Overview
7.2.3 Croda Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Croda Fish Oil EPA and DHA Product Offerings
7.2.5 Croda Recent Development
7.3 BASF
7.3.1 BASF Company Information
7.3.2 BASF Introduction and Business Overview
7.3.3 BASF Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 BASF Fish Oil EPA and DHA Product Offerings
7.3.5 BASF Recent Development
7.4 Yuwang Pharma
7.4.1 Yuwang Pharma Company Information
7.4.2 Yuwang Pharma Introduction and Business Overview
7.4.3 Yuwang Pharma Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Yuwang Pharma Fish Oil EPA and DHA Product Offerings
7.4.5 Yuwang Pharma Recent Development
7.5 GC Rieber VivoMega
7.5.1 GC Rieber VivoMega Company Information
7.5.2 GC Rieber VivoMega Introduction and Business Overview
7.5.3 GC Rieber VivoMega Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 GC Rieber VivoMega Fish Oil EPA and DHA Product Offerings
7.5.5 GC Rieber VivoMega Recent Development
7.6 Pelagia (EPAX)
7.6.1 Pelagia (EPAX) Company Information
7.6.2 Pelagia (EPAX) Introduction and Business Overview
7.6.3 Pelagia (EPAX) Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Pelagia (EPAX) Fish Oil EPA and DHA Product Offerings
7.6.5 Pelagia (EPAX) Recent Development
7.7 Golden Omega
7.7.1 Golden Omega Company Information
7.7.2 Golden Omega Introduction and Business Overview
7.7.3 Golden Omega Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Golden Omega Fish Oil EPA and DHA Product Offerings
7.7.5 Golden Omega Recent Development
7.8 TASA
7.8.1 TASA Company Information
7.8.2 TASA Introduction and Business Overview
7.8.3 TASA Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 TASA Fish Oil EPA and DHA Product Offerings
7.8.5 TASA Recent Development
7.9 KinOmega Biopharm
7.9.1 KinOmega Biopharm Company Information
7.9.2 KinOmega Biopharm Introduction and Business Overview
7.9.3 KinOmega Biopharm Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 KinOmega Biopharm Fish Oil EPA and DHA Product Offerings
7.9.5 KinOmega Biopharm Recent Development
7.10 Omega Protein
7.10.1 Omega Protein Company Information
7.10.2 Omega Protein Introduction and Business Overview
7.10.3 Omega Protein Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Omega Protein Fish Oil EPA and DHA Product Offerings
7.10.5 Omega Protein Recent Development
7.11 Huatai Phrama
7.11.1 Huatai Phrama Company Information
7.11.2 Huatai Phrama Introduction and Business Overview
7.11.3 Huatai Phrama Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Huatai Phrama Fish Oil EPA and DHA Product Offerings
7.11.5 Huatai Phrama Recent Development
7.12 AlaskOmega (Wiley Companies)
7.12.1 AlaskOmega (Wiley Companies) Company Information
7.12.2 AlaskOmega (Wiley Companies) Introduction and Business Overview
7.12.3 AlaskOmega (Wiley Companies) Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 AlaskOmega (Wiley Companies) Fish Oil EPA and DHA Product Offerings
7.12.5 AlaskOmega (Wiley Companies) Recent Development
7.13 Jiangsu Auqi Marine Biotechnology
7.13.1 Jiangsu Auqi Marine Biotechnology Company Information
7.13.2 Jiangsu Auqi Marine Biotechnology Introduction and Business Overview
7.13.3 Jiangsu Auqi Marine Biotechnology Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Jiangsu Auqi Marine Biotechnology Fish Oil EPA and DHA Product Offerings
7.13.5 Jiangsu Auqi Marine Biotechnology Recent Development
7.14 Sinomega Biotech Engineering
7.14.1 Sinomega Biotech Engineering Company Information
7.14.2 Sinomega Biotech Engineering Introduction and Business Overview
7.14.3 Sinomega Biotech Engineering Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Sinomega Biotech Engineering Fish Oil EPA and DHA Product Offerings
7.14.5 Sinomega Biotech Engineering Recent Development
7.15 Xinzhou Marine Biological Products
7.15.1 Xinzhou Marine Biological Products Company Information
7.15.2 Xinzhou Marine Biological Products Introduction and Business Overview
7.15.3 Xinzhou Marine Biological Products Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Xinzhou Marine Biological Products Fish Oil EPA and DHA Product Offerings
7.15.5 Xinzhou Marine Biological Products Recent Development
7.16 Nu-Mega (Clover)
7.16.1 Nu-Mega (Clover) Company Information
7.16.2 Nu-Mega (Clover) Introduction and Business Overview
7.16.3 Nu-Mega (Clover) Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Nu-Mega (Clover) Fish Oil EPA and DHA Product Offerings
7.16.5 Nu-Mega (Clover) Recent Development
7.17 Skuny Bioscience
7.17.1 Skuny Bioscience Company Information
7.17.2 Skuny Bioscience Introduction and Business Overview
7.17.3 Skuny Bioscience Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.17.4 Skuny Bioscience Fish Oil EPA and DHA Product Offerings
7.17.5 Skuny Bioscience Recent Development
7.18 Renpu Pharmaceuticals
7.18.1 Renpu Pharmaceuticals Company Information
7.18.2 Renpu Pharmaceuticals Introduction and Business Overview
7.18.3 Renpu Pharmaceuticals Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.18.4 Renpu Pharmaceuticals Fish Oil EPA and DHA Product Offerings
7.18.5 Renpu Pharmaceuticals Recent Development
7.19 Polaris
7.19.1 Polaris Company Information
7.19.2 Polaris Introduction and Business Overview
7.19.3 Polaris Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.19.4 Polaris Fish Oil EPA and DHA Product Offerings
7.19.5 Polaris Recent Development
7.20 Solutex
7.20.1 Solutex Company Information
7.20.2 Solutex Introduction and Business Overview
7.20.3 Solutex Fish Oil EPA and DHA Sales, Revenue, Price and Gross Margin (2020-2025)
7.20.4 Solutex Fish Oil EPA and DHA Product Offerings
